241 related articles for article (PubMed ID: 24610925)
61. Serum uric acid and eGFR_CKDEPI differently predict long-term cardiovascular events and all causes of deaths in a residential cohort.
Puddu PE; Bilancio G; Terradura Vagnarelli O; Lombardi C; Mancini M; Zanchetti A; Menotti A
Int J Cardiol; 2014 Feb; 171(3):361-7. PubMed ID: 24388539
[TBL] [Abstract][Full Text] [Related]
62. Low levels of high-density lipoprotein cholesterol increase the risk of incident kidney disease and its progression.
Bowe B; Xie Y; Xian H; Balasubramanian S; Al-Aly Z
Kidney Int; 2016 Apr; 89(4):886-96. PubMed ID: 26924057
[TBL] [Abstract][Full Text] [Related]
63. Routinely measured iohexol glomerular filtration rate versus creatinine-based estimated glomerular filtration rate as predictors of mortality in patients with advanced chronic kidney disease: a Swedish Chronic Kidney Disease Registry cohort study.
Methven S; Gasparini A; Carrero JJ; Caskey FJ; Evans M
Nephrol Dial Transplant; 2017 Apr; 32(suppl_2):ii170-ii179. PubMed ID: 28339801
[TBL] [Abstract][Full Text] [Related]
64. Chronic kidney disease, cardiovascular risk markers and total mortality in older men: cystatin C versus creatinine.
Zonoozi S; Ramsay SE; Papacosta O; Lennon LT; Ellins EA; Halcox JPJ; Whincup P; Wannamethee SG
J Epidemiol Community Health; 2019 Jul; 73(7):645-651. PubMed ID: 30890591
[TBL] [Abstract][Full Text] [Related]
65. Homoarginine, kidney function and cardiovascular mortality risk.
Tomaschitz A; Meinitzer A; Pilz S; Rus-Machan J; Genser B; Drechsler C; Grammer T; Krane V; Ritz E; Kleber ME; Pieske B; Kraigher-Krainer E; Fahrleitner-Pammer A; Wanner C; Boehm BO; März W
Nephrol Dial Transplant; 2014 Mar; 29(3):663-71. PubMed ID: 24398889
[TBL] [Abstract][Full Text] [Related]
66. Serum non-high-density lipoprotein cholesterol (non-HDL-C) levels and cardiovascular mortality in chronic hemodialysis patients.
Echida Y; Ogawa T; Otsuka K; Ando Y; Nitta K
Clin Exp Nephrol; 2012 Oct; 16(5):767-72. PubMed ID: 22374049
[TBL] [Abstract][Full Text] [Related]
67. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.
Sai E; Shimada K; Miyauchi K; Masaki Y; Kojima T; Miyazaki T; Kurata T; Ogita M; Tsuboi S; Yoshihara T; Miyazaki T; Ohsaka A; Daida H
Heart Vessels; 2016 May; 31(5):694-701. PubMed ID: 25863806
[TBL] [Abstract][Full Text] [Related]
68. Biomarkers of kidney function and prediction of death from cardiovascular and other causes in the elderly: A 9-year follow-up study.
Salminen M; Laine K; Korhonen P; Wasen E; Vahlberg T; Isoaho R; Kivelä SL; Löppönen M; Irjala K
Eur J Intern Med; 2016 Sep; 33():98-101. PubMed ID: 27370901
[TBL] [Abstract][Full Text] [Related]
69. A pooled analysis of the association of isolated low levels of high-density lipoprotein cholesterol with cardiovascular mortality in Japan.
Hirata T; Sugiyama D; Nagasawa SY; Murakami Y; Saitoh S; Okayama A; Iso H; Irie F; Sairenchi T; Miyamoto Y; Yamada M; Ishikawa S; Miura K; Ueshima H; Okamura T;
Eur J Epidemiol; 2017 Jul; 32(7):547-557. PubMed ID: 27709448
[TBL] [Abstract][Full Text] [Related]
70. Association of cholesterol levels with mortality and cardiovascular events among patients with CKD and different amounts of proteinuria.
Chen SC; Hung CC; Tsai YC; Huang JC; Kuo MC; Lee JJ; Chiu YW; Chang JM; Hwang SJ; Chen HC
Clin J Am Soc Nephrol; 2013 Nov; 8(11):1915-26. PubMed ID: 23929929
[TBL] [Abstract][Full Text] [Related]
71. Renal Function and All-Cause Mortality Risk Among Cancer Patients.
Yang Y; Li HY; Zhou Q; Peng ZW; An X; Li W; Xiong LP; Yu XQ; Jiang WQ; Mao HP
Medicine (Baltimore); 2016 May; 95(20):e3728. PubMed ID: 27196494
[TBL] [Abstract][Full Text] [Related]
72. Elevated Circulating Osteoprotegerin and Renal Dysfunction Predict 15-Year Cardiovascular and All-Cause Mortality: A Prospective Study of Elderly Women.
Lewis JR; Lim WH; Ueland T; Wong G; Zhu K; Lim EM; Bollerslev J; Prince RL
PLoS One; 2015; 10(7):e0134266. PubMed ID: 26222774
[TBL] [Abstract][Full Text] [Related]
73. Shrunken pore syndrome and mortality: a cohort study of patients with measured GFR and known comorbidities.
Åkesson A; Lindström V; Nyman U; Jonsson M; Abrahamson M; Christensson A; Björk J; Grubb A
Scand J Clin Lab Invest; 2020 Sep; 80(5):412-422. PubMed ID: 32459111
[TBL] [Abstract][Full Text] [Related]
74. Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study.
Amdur RL; Feldman HI; Dominic EA; Anderson AH; Beddhu S; Rahman M; Wolf M; Reilly M; Ojo A; Townsend RR; Go AS; He J; Xie D; Thompson S; Budoff M; Kasner S; Kimmel PL; Kusek JW; Raj DS;
Am J Kidney Dis; 2019 Mar; 73(3):344-353. PubMed ID: 30545708
[TBL] [Abstract][Full Text] [Related]
75. Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease.
Mann JFE; Fonseca V; Mosenzon O; Raz I; Goldman B; Idorn T; von Scholten BJ; Poulter NR
Circulation; 2018 Dec; 138(25):2908-2918. PubMed ID: 30566006
[TBL] [Abstract][Full Text] [Related]
76. Long-term outcomes of patients with stable coronary disease and chronic kidney dysfunction: 10-year follow-up of the Medicine, Angioplasty, or Surgery Study II Trial.
Lima EG; Charytan DM; Hueb W; de Azevedo DFC; Garzillo CL; Favarato D; Linhares Filho JPP; Martins EB; Batista DV; Rezende PC; Hueb AC; Ramires JAF; Kalil Filho R
Nephrol Dial Transplant; 2020 Aug; 35(8):1369-1376. PubMed ID: 30590726
[TBL] [Abstract][Full Text] [Related]
77. Carotid intima-media thickness is an independent predictor of all-cause mortality and cardiovascular morbidity in patients with diabetes mellitus type 2 and chronic kidney disease.
Roumeliotis A; Roumeliotis S; Panagoutsos S; Theodoridis M; Argyriou C; Tavridou A; Georgiadis GS
Ren Fail; 2019 Nov; 41(1):131-138. PubMed ID: 30909780
[TBL] [Abstract][Full Text] [Related]
78. Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease.
Baek SH; Cha RH; Kang SW; Park CW; Cha DR; Kim SG; Yoon SA; Kim S; Han SY; Park JH; Chang JH; Lim CS; Kim YS; Na KY
Tohoku J Exp Med; 2017 Aug; 242(4):281-290. PubMed ID: 28824047
[TBL] [Abstract][Full Text] [Related]
79. Blood kidney injury molecule-1 predicts short and longer term kidney outcomes in patients undergoing diagnostic coronary and/or peripheral angiography-Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study.
Ibrahim NE; McCarthy CP; Shrestha S; Lyass A; Li Y; Gaggin HK; Simon ML; Massaro JM; D'Agostino RB; Garasic JM; van Kimmenade RR; Januzzi JL
Am Heart J; 2019 Mar; 209():36-46. PubMed ID: 30641399
[TBL] [Abstract][Full Text] [Related]
80. Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort.
Pammer LM; Lamina C; Schultheiss UT; Kotsis F; Kollerits B; Stockmann H; Lipovsek J; Meiselbach H; Busch M; Eckardt KU; Kronenberg F;
J Intern Med; 2021 Dec; 290(6):1219-1232. PubMed ID: 34342064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
